Lv451
530 积分 2024-05-08 加入
Preclinical activity of sacituzumab govitecan in TROP2-positive low-grade serous ovarian cancer patient-derived xenograft models
10天前
已关闭
Preclinical activity of sacituzumab govitecan in TROP2-positive low-grade serous ovarian cancer patient-derived xenograft models
12天前
已关闭
曲妥珠单抗-药物共轭物(T-DM1)临床前药物代谢动力学研究及人体药物代谢动力学预测
30天前
已完结
抗体偶联药物的分子特点及其药代动力学研究考虑
30天前
已完结
胰腺癌肿瘤免疫微环境的特征及其免疫治疗策略
1个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1个月前
已完结
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice
1个月前
已完结
FAP-1分子对卵巢癌细胞株SKOV3凋亡的影响
1个月前
已完结
FAP-1的研究进展
1个月前
已完结
FAP-1与Fas系统
1个月前
已完结
皖公网安备34019202002308
